中国现代医学杂志
中國現代醫學雜誌
중국현대의학잡지
CHINA JOURNAL OF MODERN MEDICINE
2004年
8期
21-24
,共4页
王存邦%欧英贤%白海%魏亚明%欧建锋%慕海霞%王晓静
王存邦%歐英賢%白海%魏亞明%歐建鋒%慕海霞%王曉靜
왕존방%구영현%백해%위아명%구건봉%모해하%왕효정
重组人粒细胞集落刺激因子%动员%CD34+细胞%T淋巴细胞亚群
重組人粒細胞集落刺激因子%動員%CD34+細胞%T淋巴細胞亞群
중조인립세포집락자격인자%동원%CD34+세포%T림파세포아군
G- CSF%mobilization%CD34 + cell%T lymphocyte subsets
目的探讨应用化疗+G-CSF方法动员外周血干细胞时,恶性血液病患者的骨髓及外周血CD34+细胞和T细胞亚群的变化特点.方法 16例拟行自体外周血干细胞移植患者,在应用化疗+G-CSF方法动员外周血干细胞期间,应用流式细胞仪测定骨髓及外周血CD34+和T细胞亚群动态变化情况.结果 1.恶性血液病患者在应用G-CSF前,骨髓中CD34+细胞的初始值为(0.52±0.31)%.应用G-CSF 48 h后,CD34+细胞测定值为(1.22±0.42)%,较前有明显增加(P<0.001).CD34+细胞的高峰值出现在应用G-CSF 96 h后,为(2.23±0.34)%,较未应用G-CSF时差异显著(P<0.001).2.恶性血液病患者在应用G-CSF前,外周血CD34+细胞测定值为(0.39±0.27)%.在应用G-CSF 72 h后外周血中CD34+细胞的测定值为(1.29±0.64)%,较前有明显增加(P<0.001).应用G-CSF96 h后,CD34+细胞的测定值达高峰,为(1.41±0.73)%,较未应用G-CSF前差异显著(P<0.001).3.无论是否应用G-CSF,恶性血液病患者的T淋巴细胞亚群比例均处于倒置状态,应用G-CSF后随CD34+细胞的逐渐增加,T淋巴细胞亚群变化不明显(P>0.05).结论恶性血液病患者,在应用化疗+G-CSF动员外周血干细胞时,其骨髓及外周血CD34+细胞和T细胞亚群的动态变化各有其特点.
目的探討應用化療+G-CSF方法動員外週血榦細胞時,噁性血液病患者的骨髓及外週血CD34+細胞和T細胞亞群的變化特點.方法 16例擬行自體外週血榦細胞移植患者,在應用化療+G-CSF方法動員外週血榦細胞期間,應用流式細胞儀測定骨髓及外週血CD34+和T細胞亞群動態變化情況.結果 1.噁性血液病患者在應用G-CSF前,骨髓中CD34+細胞的初始值為(0.52±0.31)%.應用G-CSF 48 h後,CD34+細胞測定值為(1.22±0.42)%,較前有明顯增加(P<0.001).CD34+細胞的高峰值齣現在應用G-CSF 96 h後,為(2.23±0.34)%,較未應用G-CSF時差異顯著(P<0.001).2.噁性血液病患者在應用G-CSF前,外週血CD34+細胞測定值為(0.39±0.27)%.在應用G-CSF 72 h後外週血中CD34+細胞的測定值為(1.29±0.64)%,較前有明顯增加(P<0.001).應用G-CSF96 h後,CD34+細胞的測定值達高峰,為(1.41±0.73)%,較未應用G-CSF前差異顯著(P<0.001).3.無論是否應用G-CSF,噁性血液病患者的T淋巴細胞亞群比例均處于倒置狀態,應用G-CSF後隨CD34+細胞的逐漸增加,T淋巴細胞亞群變化不明顯(P>0.05).結論噁性血液病患者,在應用化療+G-CSF動員外週血榦細胞時,其骨髓及外週血CD34+細胞和T細胞亞群的動態變化各有其特點.
목적탐토응용화료+G-CSF방법동원외주혈간세포시,악성혈액병환자적골수급외주혈CD34+세포화T세포아군적변화특점.방법 16례의행자체외주혈간세포이식환자,재응용화료+G-CSF방법동원외주혈간세포기간,응용류식세포의측정골수급외주혈CD34+화T세포아군동태변화정황.결과 1.악성혈액병환자재응용G-CSF전,골수중CD34+세포적초시치위(0.52±0.31)%.응용G-CSF 48 h후,CD34+세포측정치위(1.22±0.42)%,교전유명현증가(P<0.001).CD34+세포적고봉치출현재응용G-CSF 96 h후,위(2.23±0.34)%,교미응용G-CSF시차이현저(P<0.001).2.악성혈액병환자재응용G-CSF전,외주혈CD34+세포측정치위(0.39±0.27)%.재응용G-CSF 72 h후외주혈중CD34+세포적측정치위(1.29±0.64)%,교전유명현증가(P<0.001).응용G-CSF96 h후,CD34+세포적측정치체고봉,위(1.41±0.73)%,교미응용G-CSF전차이현저(P<0.001).3.무론시부응용G-CSF,악성혈액병환자적T림파세포아군비례균처우도치상태,응용G-CSF후수CD34+세포적축점증가,T림파세포아군변화불명현(P>0.05).결론악성혈액병환자,재응용화료+G-CSF동원외주혈간세포시,기골수급외주혈CD34+세포화T세포아군적동태변화각유기특점.
Objective: To approach what changes happen about CD34 + cells and T lymphocyte subsets after using chemotherapy plus G - CSF with patients. Methods: Flow cytometry was used to detect the changes of the percentages of CD34 + cells and T lymphocyte cell subsets in 16 cases of patients when they were treated with chemotherapy and injected with G - CSF for mobilizing peripheral blood stem cells. Results: 1. Without using G - CSF, the percentages of CD34 + cells in the bone marrow of the patients ranged in (0.52 ± 0.31) %. After Using G - CSF for 48hrs, the percentages ranged in (1.22±0.42)%,obviously increased compared with those of no using G - CSF (P<0.001).After 96hrs the highest percentages were reached and ranged in (2.23 ± 0.34) % , significant increased compared with those of no using G - CSF (P<0.001). 2. Without using G - CSF, the percentages of CD34 + cells in peripheral blood of the patients ranged in (0.39 ± 0.27 ) %. After using G - CSF for 72 hours, they ranged in ( 1.29±0.64)%, obviously increased compared with those of no using G- CSF (P<0.001). After 96 hrs the highest percentages were reached and ranged in (1.41±0.73) %, significant increased compared with those of no using G -CSF (P<0.001). 3. CD4/CDs of the patients were abnormal (<1) whether in bone marrow cells or peripheral blood cells. There were no obvious changes of T lymphocyte subsets in the patients except that CD34 + cells increased gradually(P>0.05) when using G -CSF for some days . Conclusions:The dynamic change of the percentages of CD34 +cells and T lymphocyte subsets in bone marrow or peripheral blood of patients with CR complete remission has itself characteristics after using chemotherapy plus G - CSF for days.